Large Scale Patient Notification

In a previous blog, I talked about involving the Infection Preventionist in diversion of injectable medications because of their expertise in disease transmission and the public health impact. Should there be a case of disease transmission from an employee to a patient, does your facility have the following?

  • written protocols for launching a large response that would include:
    • obtaining patient contact information
    • writing notification letters
    • orchestrating testing including writing the orders for testing
    • determining payment for testing
    • monitoring positive results
    • setting up a hotline for the public to call with questions
    • etc

It is a daunting task and one that most facilities probably never need to do, but when you do, having procedures in place to do it will be very beneficial.

If there is anyone out there who has gone through this process and is willing to share their experience and lessons learned, please reach out so we can connect.

Terri Vidals
Terri Vidals

Terri has been a pharmacist for over 30 years and is a drug diversion mitigation and monitoring subject matter expert. Her years of experience in various roles within hospital pharmacy have given her real-world insight into risk, compliance, and regulatory requirements, as well as best practices for medication and patient safety.

Subscribe to Drug Diversion Insights with Terri Vidals to learn more about diversion mitigation.


Recent Posts

Download White Paper